Reuters logo
BRIEF-Coherus Biosciences Q4 loss per share $1.71
2017年3月13日 / 晚上8点20分 / 8 个月前

BRIEF-Coherus Biosciences Q4 loss per share $1.71

March 13 (Reuters) - Coherus Biosciences Inc:

* Coherus Biosciences reports fourth quarter and full year 2016 corporate highlights and financial results

* Q4 revenue $844,000 versus $10.2 million

* Q4 revenue view $70.7 million -- Thomson Reuters I/B/E/S

* Q4 loss per share $1.71

* Q4 earnings per share view $-1.11 -- Thomson Reuters I/B/E/S

* Coherus biosciences inc- cash and cash equivalents totaled $124.9 million as of December 31, 2016, compared to $159.7 million as of September 30, 2016 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below